These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 13641562)

  • 21. Effect of silicate on Gram staining and viability of pneumococci and other bacteria.
    MACLEOD CM; ROE AS
    J Exp Med; 1956 Apr; 103(4):453-63. PubMed ID: 13306854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The microbiologic aspects, including diagnosis, of beta-hemolytic streptococcal and enterococcal infections.
    Kaufhold A; Ferrieri P
    Infect Dis Clin North Am; 1993 Jun; 7(2):235-56. PubMed ID: 8345168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New antimicrobial peptide active against Gram-positive pathogens.
    Jasir A; Kasprzykowski F; Lindström V; Schalén C; Grubb A
    Indian J Med Res; 2004 May; 119 Suppl():74-6. PubMed ID: 15232166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cephalosporins in gram-positive infections.
    Symonds J; Geddes AM
    Drugs; 1987; 34 Suppl 2():121-34. PubMed ID: 3319496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of cefepime compared with other antibiotics against gram-positive bacteria and cefuroxime-resistant gram-negative bacteria.
    Wang FD; Liu IM; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):408-13. PubMed ID: 9699393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variation in the group-specific carbohydrate of group A streptococci. I. Immunochemical studies on the carbohydrates of variant strains.
    McCARTY M; LANCEFIELD RC
    J Exp Med; 1955 Jul; 102(1):11-28. PubMed ID: 14392237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemical study of nutritionally variant streptococci.
    van de Rijn I; George M
    J Immunol; 1984 Oct; 133(4):2220-5. PubMed ID: 6470489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
    Tariq TM
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro activity of ertapenem against clinical bacterial isolates in 69 Spanish medical centers (E-test study)].
    Gobernado M; Sanz-Rodríguez C; Villanueva R; Torroba L; Redondo E; González-Esteban J
    Rev Esp Quimioter; 2007 Dec; 20(4):395-408. PubMed ID: 18563213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that mycoplasmas, gram-negative bacteria, and certain gram-positive bacteria share a similar protein antigen.
    Sasaki T
    J Bacteriol; 1991 Apr; 173(7):2398-400. PubMed ID: 2007558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of A-16686, a new glycopeptide.
    Neu HC; Neu NM
    Chemotherapy; 1986; 32(5):453-7. PubMed ID: 3757587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental infection of the skin in the hamster simulating human impetigo. III. Interaction between staphylococci and group A streptococci.
    Dajani AS; Wannamaker LW
    J Exp Med; 1971 Sep; 134(3 Pt 1):588-99. PubMed ID: 15776563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.
    Kayser FH; Novak J
    Am J Med; 1987 Apr; 82(4A):33-9. PubMed ID: 3555058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
    Focht J; Klietmann W; Nösner K
    Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation occurring in group A streptococci during human infection; progressive loss of M substance correlated with increasing susceptibility to bacteriostasis.
    ROTHBARD S; WATSON RF
    J Exp Med; 1948 Jun; 87(6):521-33. PubMed ID: 18858642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of daptomycin against clinical isolates of Gram-positive bacteria.
    Piper KE; Steckelberg JM; Patel R
    J Infect Chemother; 2005 Aug; 11(4):207-9. PubMed ID: 16133715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
    Jones RN; Kirby JT; Rhomberg PR
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation in the M antigen of group A streptococci: reassortment of type-specific markers and possible antigenic drift.
    Cleary P; Johnson D; Wannamaker L
    J Infect Dis; 1979 Nov; 140(5):747-57. PubMed ID: 93611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host-parasite factors in group A streptococcal infections. A comparative study of streptococcal pyrogenic toxins and gram-negative bacterial endotoxin.
    CREMER N; WATSON DW
    J Exp Med; 1960 Dec; 112(6):1037-53. PubMed ID: 13696375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.